Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team to help clients develop the expert partnerships they need at all points in the product launch cycle. We believe that KOL relationship-building can transform market performance. We invest all our energies in helping our clients to do it well.
Kendle Healthcare is dedicated to the two key phases of KOL development: finding the right people, and working with them in the right way. Kendle’s research division conducts identification projects which deliver powerful insights into the clinician landscape in any therapy area, large or small. We take a unique and considered approach to capturing individual experts’ strengths and interests. Our findings are delivered in visually dynamic formats tailored to the working needs of medical, marketing and sales teams. Our methodology is complex, but our aim is simple: provide peace of mind by ensuring our clients identify the most influential individuals in any therapy area.
Kendle’s engagement team partners with clients to design and implement a KOL programme which gets the best from those individuals. Our strategic consultancy is built on our philosophy of long-term relationship-building. Whatever the engagement activity, we never forget that we are facilitating a partnership which can and should be productive for both sides. Whatever your needs, we are the experts on experts.
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
We live in a hyper-connected world. This has clear benefits for the health of our communities, our businesses and our planet. But are those connections working for or against your…
Accession was a born from a passion and a vision. A passion to harness the power of market access to ensure patients gain access to life changing medicines and devices….
AMICULUM works with the global healthcare industry to bring science to life across the product lifecycle from early opportunity assessment through to launch and beyond. By listening to the changing…
Avalere Health is a leading global commercialization partner for the biopharmaceutical, medical technology, and wellness industries. Working from advisory to performance, we combine our knowledge and expertise across our disciplines…
AXON, a global healthcare consulting firm, harnesses the diverse expertise of our talented team to help our clients create science-based strategies and drive stakeholder activation. AXON serves the healthcare communications…
Bedrock Healthcare Communications is an award-winning, independent agency founded in 2011. We partner with healthcare professionals, patients, and global pharmaceutical and biotech clients to translate science into engagement.
A specialist Advertising and Med Comms agency dedicated to bringing much-needed creativity to healthcare marketing. We believe that brilliant ideas aren’t just good for business, they can make a positive…
Here at Cuttsy+Cuttsy, we believe in making the world a better place by bringing trusted, accessible information to all and supporting understanding and outcomes across trials, treatments and beyond.
Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop great pharmaceutical brands. We do this by creating Pharmacohesion™.
Welcome to EatMoreFruit – a top 10 independent global healthcare communications agency based in the heart of London. Specialising in PR, digital, influencer & communication services, we deliver creative &…
OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic Performance (ESP) in medical communications since 2007 through impactful strategy,…
Fox&cat is an award-winning healthcare communications agency which creates inspirational campaigns and programmes that exceed expectations. Priding itself on delivering outstanding outcomes with meaningful impact, fox&cat is a vehemently purpose-driven…
We guide healthcare and life sciences organisations through digital transformation. Simplifying the complex world of tech and marketing, we create impactful assets and strategies to drive long-term growth and positive…
We’re a digital CX agency collaborating with healthcare and pharmaceutical organisations to help them connect more deeply with their audiences through meaningful digital experiences. Our teams of specialists help clients…
We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…
Advertising, Branding, Clinical Research, Conference/meetings/events, Creative and design, Digital communications, Management consultancies, Market access, Market research, Marketing consultancies, Medical communications, Medical education, Patient support and adherence, Public relations, Regulatory affairs
We are the Havas Lynx. Devoted to fresh thinking. Changing the way the world does healthcare communications for the better. Great talent. Great ideas. Great outcomes.
We are market research experts in the healthcare, pharmaceutical, device and diagnostics space, and have a wealth of experience in a wide range of therapy areas. Our scientifically grounded approaches…
Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education to life science companies from around the globe since 2008.
Welcome to Inizio. Your market-leading commercialization partner, providing tailored, innovative solutions to help health and life sciences companies with their clinical development and commercialization journeys, maximizing patient access.
We are the world’s most celebrated and awarded Medical Communications agencies. We are 800 experts obsessed with combining science, creativity and technology to exceptional medical communications solutions for our clients.
Company Details
Latest Content from PMHub
White Papers and Resources | March 1, 2016 | Blue Latitude Health
In 2016, it’s time to update our model for the customer journey. Customer Experience Consultant Anna Tamasi talks us through the future of journey mapping.
White Papers and Resources | February 29, 2016 | Say Communications
Alastair Kent, OBE, the Director of Genetic Alliance UK and chair of Rare Disease UK tells us why it’s so important to care about rare disease and why we should...
White Papers and Resources | February 24, 2016 | Say Communications
Patrick Ladbury, the Director at the NSMC delves further into the barriers to behaviour change, and offers us tricks of the trade in his second instalment.
White Papers and Resources | February 23, 2016 | Anthill Agency
What’s the point of marketing content that doesn’t get used?
White Papers and Resources | February 19, 2016 | Blue Latitude Health
Head of Commercial Matt Bolton of Blue Latitude Health breaks down what we mean when we talk about eliminating the last silos in pharma marketing.
Press Releases | February 19, 2016 | Blue Latitude Health
Blue Latitude Health’s Managing Director, Martin Brass, and Johnson & Johnson’s Director, David McKimm, to co-present on the topic “Optimising Your Marketing Spend in New Ways to Create Value for...
White Papers and Resources | February 17, 2016 | Blue Latitude Health
In this article, Customer Experience Consultant Anna Tamasi from Blue Latitude Health highlights the most common usability and user experience implications that the digitalisation of healthcare poses on doctors professional...
White Papers and Resources | February 15, 2016 | Say Communications
Our new blog highlights the challenges for communicating to consumers who are 50+ and how they must be tackled in order to create marketing opportunities.
Press Releases | February 11, 2016 | Lucid Group Communications Limited
Lucid CEO discusses the increasing importance placed on real-world data to demonstrate value
White Papers and Resources | February 9, 2016 | Inizio
Our latest Free Thinking white paper series explores what the global outlook is like for new immunotherapy products and asks key opinion leaders and payers how they’re faring both clinically...